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Summary 
Infection with the human immunodeficiency virus (HIV) results in immunosuppression and 
depletion of circulating CD4 + T cells. Since the thymus is the primary organ in which T cells 
mature it is of interest to examine the effects of HIV infection in this tissue.  HIV infection has 
been demonstrated in the thymuses of infected individuals and thymocytes have been previously 
demonstrated to be susceptible to HIV infection both in vivo, using the SCID-hu mouse, and 
in vitro. The present study sought to determine which subsets of thymocytes were infected in 
the SCID-hu mouse modal and to evaluate HIV-related alterations in the thymic microenvironment. 
Using two different primary HIV isolates, infection was found in CD4 +/CD8 + double positive 
thymocytes as well as in both the CD4 + and CD8 + single positive subsets of thymocytes. The 
kinetics of infection and resulting viral burden differed among the three thymocyte subsets and 
depended on which HIV isolate was used for infection. Thymic epithelial (TE) cells were also 
shown to endocytose virus and to often contain copious amounts of viral RNA in the cytoplasm 
by in situ hybridization, although productive infection of these cells could not be definitively 
shown. Furthermore, degenerating TE cells were observed even without detection of HIV in 
the degenerating cells. Two striking morphologic patterns of infection were seen, involving either 
predominantly thymocyte infection and  depletion,  or  TE  cell involvement with  detectable 
cytoplasmic viral RNA and/or TE cell toxicity. Thus, a variety of cells in the human thymus 
is susceptible to HIV infection, and infection with HIV results in a marked disruption of the 
thymic microenvironment leading to depletion of thymocytes and degeneration of TE ceils. 
D 
epletion of mature CD4 +  T  lymphocytes associated 
with severe immunosuppression is characteristic of in- 
fection with the HIV (1). The mechanism of CD4 § T  cell 
depletion have been postulated to include direct lytic infec- 
tion by HIV (2); destruction of uninfected cells coated with 
the soluble viral envelope protein, gp120, by cytotoxic effector 
cells and antibody-dependent cellular cytotoxicity (3, 4); apop- 
tosis of CD4 + T  cells due to abnormal signaling by HIV 
proteins (5); or autoimmune phenomena (6). HIV infection 
of either bone marrow or thymic precursor cells leading to 
their destruction or failure to give rise to more mature progeny 
could  also  contribute  to  peripheral  blood  CD4 +  T  cell 
depletion. In this regard, this laboratory and others (7,  8) 
have previously shown that immature thymocyte precursors 
as well as CD34 + bone marrow progenitor cells (9) can be 
infected with HIV in vitro.  It has also been demonstrated 
that CD34 + progenitor cells are infected in vivo in some in- 
dividuals (10) and that human thymocytes can be reprodu- 
cibly infected with primary isolates of HIV in vivo using the 
SCID-hu mouse model (11). 
Failure to regenerate mature T lymphocytes could also occur 
if the thymic microenvironment is damaged by HIV infec- 
tion. Autopsy and biopsy studies have demonstrated that the 
thymus in HIV-infected individuals is abnormal with efface- 
ment of the medulla and cortex, marked involution, and deple- 
tion of epithelial elements as well as thymocytes (12-16). 
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mic (TE) 1 cell may be  a primary target  for HIV-induced 
injury (15). 
The SCID-hu xenograft mouse model has been developed 
as a tool for studying ongoing human thymopoiesis (17,  18, 
and for a review see reference 19). Mature lymphocytes within 
the SCID-hu mouse have been shown to be functionally and 
phenotypically normal (20, 21),  and the morphology of the 
SCID-hu  thymus  appears  similar  to  the  normal  human 
thymus, with distinct medullary and cortical compartments, 
Hassall's corpuscles, and an appropriate distribution of ma- 
ture and immature thymocytes (17). 
In the present study, the SCID-hu mouse was employed 
to further delineate the subsets of thymocytes that are sus- 
ceptible to in vivo infection with HIV and to examine the 
effects of HIV on the thymic microenvironment. This study 
demonstrates  that  both  CD4 +  and  CD8 §  single positive 
(SP)  thymocytes as well as  CD4+/CD8 +  double positive 
(DP) cells  are infected with HIV in the SCID-hu thymus. 
Furthermore,  we  demonstrate  not  only alterations  in  the 
microenvironment of the HIV-infected thymus but also the 
presence of HIV within TE cells. 
Materials and Methods 
Infection of SCID-hu Mice.  The SCID-hu chimeric  mice used 
in this study are C.B-17 scid/scid mice into which small pieces (ml 
mm  3 each) of human second trimester fetal thymus and liver have 
been implanted under the renal capsule. Over several months, the 
tissues vascularize, fuse, and mature into a thymic structure that 
supports ongoing human thymopoiesis (17, 18). SCID-hu mice (SyS- 
temix, Inc., Palo Alto, CA) were used 4-6 mo after implantation 
of human tissue. To minimize variables, each separate experiment 
used littermate mice reconstituted with tissue from the same fetal 
donor. Six different experiments using over 65 mice were performed 
for this study. Mice were anesthetized and a flank incision made 
to expose the kidney with the thymic implant. Sterile normal sa- 
line or 400-4,000  tissue  culture infectious  doses0 of HIV (in a 
small volume) was injected directly into the thymus and the flank 
incision closed. Two different primary HIV viral isolates, the molecu- 
larly cloned JK-CSF (22) and the early passage highly cytopathic 
isolate SM, were used in these experiments. At varying times after 
infection, individual mice were killed and the human thymus re- 
moved. Small pieces of tissue were placed immediately in fixative 
for immunohistochemistry (IHC), in situ hybridization (ISH), and 
transmission  electron  microscopy (TEM). Total thymocytes har- 
vested from the remaining tissue by gentle mechanical dissociation 
were immediately stained for phenotypic analysis and cell sorting. 
Because the amount of thymic tissue from which thymocytes were 
harvested varied according to the initial size of the particular thymus 
and  the amount of tissue  taken for histologic studies,  variable 
numbers of thymocytes were obtained from each mouse,  so that 
total thymocyte cell counts were not meaningful when evaluating 
the effect of  infection on thymocyte depletion. However, depletion 
was  evaluated during careful  histologic examination of various 
thymic samples. Additionally,  FACS  |  analysis gives reproducible 
t Abbreviations used in thispatxor:  DN, double  negative; DP, double  positive; 
IHC, immunohistochemistry;  ISH, in situ hybridization;  SP, single  positive; 
TE, thymic  epithelial; TEM, transmission  electron  microscopy;  TN, triple 
negative. 
results regarding the CD4/CD8 staining pattern of total thymo- 
cytes so that preferential depletion of thymocyte subsets could be 
evaluated. 
Fluorescence Activated Cell Sorting and Analysis.  Total thymocytes 
were incubated  on ice with anti-CD4 (anti-Leu 3a  +  3b FITC, 
Becton Dickinson & Co., Mountain View, CA) followed by staining 
with anti-CD8 (anti-Leu 2a PE, Becton Dickinson & Co.) according 
to the manufacturer's recommendations.  Thymocytes were stained 
with a nonreactive, isotype-matched mAb for background controls. 
Labeled thymocytes were sorted using an Epics C flow cytometer 
(Coulter Corp., Hialeah, FL) equipped with a 5W argon laser with 
a 488-nm excitation wavelength, and sorting logic was controlled 
using log red versus log green fluorescence bit map gating. Cell 
aggregates and debris were eliminated using forward angle light 
scatter gates. Spectral overlap between cells stained with specific 
antibody and those incubated with FITC or PE isotype controls 
was electronically compensated using analog subtraction. Cells were 
sorted at a rate of m3,000 cells/second with coincidence abort en- 
gaged. Cells were sorted into three fractions: CD4+CD8 + DP and 
CD4+CD8 -  and CD4-CD8 + SP cells. Sorted cells were analyzed 
for purity using machine parameters identical to those for sorting. 
In general,  the populations were >98% pure with the majority 
of sorts yielding subsets of 99% purity. Contaminating cells were 
usually <1% CD4-CD8-  double negative (DN) or DP in the SP 
fractions and CD4 + or CD8 + SP cells in the DP fraction. Sorted 
cells were washed and pelleted in PBS and frozen as dry pellets 
for detection of HIV DNA and KNA by PCR analysis. 
RNA  and DNA PCR.  DNA PCR was performed as previ- 
ously published (23). Briefly, frozen cell pellets were lysed at a con- 
centration of 10  s cells per 50 #1,  and DNA from this number 
of cells analyzed.  Primers  used were SK38/39 (gag  1551-1578/ 
1638-1665) and SK70/JG69 (env 7841-7875/7959-7937) (Synthecell 
Corp., Rockville, MD). Reactions (50 #1 of DNA lysate, 50 pmol 
of  each  primer,  200  #M  each  of  the  four  deoxynucleotide 
triphosphates [Boehringer  Mannheim, Indianapolis,  IN]  10 mM 
Tris-HC1, 2.5 mM MgClz, 50 mM KC1, 0.2% gelatin, and 2 U 
Taq polymerase [Perkin-Elmer Cetus, Norwalk, CT] in 100 #1 total 
volume) were run for 31 cycles of denaturation (94~  annealing 
(55~  and extension (72~  Amplified products were detected 
by liquid hybridization to 32p-labeled ATP end-labeled probes (SK 
19 [gag 1595-1635] or SK69 [env 7922-7942], respectively) and ana- 
lyzed on 10% polyacrylamide gels followed by exposure  to film 
(Eastman Kodak Co., Rochester, NY) for varying lengths of time. 
For quantification of viral burden, serial dilutions of the lysed sample 
DNA were added to DNA from 10  s Jurkat cells and amplified as 
described. Signals on autoradiography were compared with those 
from simultaneously run dilutions of ACH-2 cells, a chronically 
infected T cell line that contains one provirus  per cell, as previ- 
ously described  (24). 
RNA PCR was performed according to the method of Graziosi 
et al. (25). Briefly, RNA was isolated from frozen cell pellets using 
the RNAzol method (Tel-Test, Inc., Friendswood, TX) followed 
by isopropanol and then ethanol precipitations.  Samples were then 
treated with DNase (Boehringer Mannheim) at room temperature 
for 1 h with frequent vortexing, followed by heat inactivation  of 
the DNase and immediate use of the samples in the PCR reaction. 
Reverse transcription and CDNA amplification  were carried out 
in the same reaction mixture without addition of reagents between 
reactions, so that reverse transcription was directed by the antisense 
primer.  The reaction mixture differed from that for DNA PCK 
only in that primers were used at 250 pmol each and 25-30 U AMV 
reverse transcriptase  (K'I~ Life Sciences, Inc., St. Petersburg,  FL) 
were added initially to each reaction. Reverse transcription  was car- 
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same parameters as those used for DNA PCR for 35 cycles. Reac- 
tion products were analyzed as for DNA PCR. SK38/39 primers 
with the SK19 probe were used to detect unspliced gag RNA and 
the TR-5/TR-3 (5953-5974/8414-8395) primer pair with the TR-4 
probe (5975-5999) used to detect spliced mRNA for the tat/rev 
messages. With each experiment, RNA was extracted in parallel 
from 8E5 cells, a chronically HIV-infected T cell line that constitu- 
tively expresses  HIV (26). The isolated RNA was divided into two 
equal portions each representing the RNA derived from 1,000 cells 
and run either with or without the addition of the RT enzyme 
to serve as positive and negative controls. 
In Situ Hybridization/lmmunohistocheraistry. ISH/IHC was per- 
formed by a procedure described at length dsewhere (27). Briefly, 
silanized slides  were deparafl~nized,  acetyhted, and hybridized with 
a truncated HIV probe representing all of the HIV-1 genome. After 
hybridization, the slides were exhaustively washed, digested with 
RNase, and coated with Kodak NTB3 emulsion. After 4-d exposure, 
the slides  were developed  and stained with hematoxylin. Combined 
ISH/IHC stains were performed using the method described by 
Spiegel et al. (28). Lymphocyte mAbs used in this study were ob- 
tained from Dako Corp. (Carpinteria, CA), and AE1 and AE3 from 
Boehringer Mannheim. 
TEM.  Small  pieces (4-8,  <1 mm) of thymic explant, fixed, 
at least overnight, in 2.5% glutaraldehyde (buffered to pH 7.2 with 
0.1 M Na cacodylate buffer), were postosmicated, dehydrated in 
increasing concentrations of ethanol and propylene oxide, and em- 
bedded in Spurr's epoxy (29). 1/~m, semi-thin plastic sections were 
cut with glass knives and stained with methylene blue, azure-II, 
and basic fuchsin. The sections were analyzed by light microscopy 
and at least two blocks were sdected for ultrastructural study. Thin 
sections (600 A) were cut with diamond knives, mounted on copper 
grids, stained with uranyl acetate and lead citrate, and examined 
on a Zeiss EM 10 operating at 60 kv. 
Results 
Maturation of the Human Thymus in SCID-hu Mic~  SCID-hu 
mice were harvested at varying times after intrathymic injec- 
tion of either sterile normal saline or HIV in saline. The typ- 
ical mock-infected thymic explant had a normal histologic 
appearance (Fig.  1 A), consistent with previous reports (17, 
18).  Specifically, thymic lobules were present with normal 
appearing Hassall's  corpusdes in the medullary region, and 
IHC staining for HLA-DR revealed a dense interconnected 
stromal network most striking in the medulla (Fig.  1 B), 
which is a previously reported normal finding in the human 
thymus (30). Thus, as demonstrated in these experiments and 
previously (17, 18), the thymus which develops  in the SCID-hu 
mouse appears to have the major features of normal human 
thymus. 
Histology of the HIV-infected Thymus.  An HIV-infected 
thymus is shown in Fig. 1 C and differs markedly from the 
mock-infected thymus shown in Fig. 1 A. The HIV-infected 
thymic explant has a large fibrous component, more adipose 
tissue (suggestive of the occurrence of atrophy), less well 
demarcated cortical/medullary  junctions, and varying numbers 
of preserved Hassall's  corpuscles. ISH gives a signal consis- 
tent with the presence of large amounts of HIV RNA (Fig. 
1 D). In contrast to what has been shown previously in the 
infected hyperplastic lymph node, where much of the RNA 
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represents extraceUular virions attached to processes  of fol- 
licular dendritic cells (31,  32),  the HIV RNA detected in 
the thymus is most likely intraceilular mRNA since the signal 
does not increase after protease digestion (data not shown). 
When ISH for HIV was combined with IHC staining for 
a variety of antigens,  it was found that both  CD4 + and 
CD4-  cells were infected with HIV whereas macrophages 
did not appear to be infected (data not shown). 
Two different viral isolates were used in these experiments 
and varying degrees of thymocyte depletion were observed 
histologically. Fig. 2 shows several examples of thymuses that 
were stained for cytokeratins, a pink stain that specifically 
identifies the TE cell. At 8 wk after infection with the JR- 
CSF isolate, minimal thymocyte depletion was observed, and 
the densely packed thymocytes tend to obscure the under- 
lying TE cell network (Fig.  2 A). In comparison, Fig. 2 B 
shows a thymus harvested 3 wk after infection with the SM 
isolate.  The diminished number of thymocytes allows one 
to now readily identify the presence of pink-stained, keratin- 
containing TE cells in an intricate supporting network. Similar 
thymocyte depletion was observed in thymuses infected with 
the JR-CSF isolate at 12 wk after infection with discrete foci 
of cells staining positively by ISH for HIV RNA clearly visible 
(data not shown). Some areas of these thymuses contained 
clearly identified TE cells that were negative by ISH for HIV 
in the same field as keratin-negative cells stained intensely 
positive by ISH that were likely thymocytes (Fig. 2 C). How- 
ever, further examination of these thymocyte-depleted tissues 
also revealed keratin-staining cells that were clearly positive 
by ISH for intracellular HIV RNA (Fig.  2 D).  Thus,  the 
use of HIV ISH combined with IHC for a variety of cell- 
associated  antigens  resulted  in  the identification  of both 
CD4 + and CD4-  HIV-infected thymocytes, as well as the 
detection of TE cells containing HIV RNA. 
Evaluation of Viral Burden and Viral Expression in Thymo- 
cytesfrom the SCID-hu Thymus.  Because many of the HIV- 
positive cells on ISH were CD4- but appeared morpholog- 
ically to be thymocytes, we determined further which subsets 
of thymocytes were infected with HIV and the kinetics of 
this  infection.  Total  thymocytes were harvested from the 
human thymic implants at progressively longer times after 
infection and sorted into highly purified SP (CD4 + SP or 
CD8 +  SP)  or  CD4+/CD8 +  DP  subsets.  Unfractionated 
total thymocytes were also analyzed. Fig. 3 shows the results 
of DNA PCR performed on sequentially obtained thymo- 
cyte subsets in one representative experiment using the HIV 
primary isolate JR-CSF for infection. By 1 wk after infec- 
tion, a positive signal forgag DNA can be seen in the unfrac- 
tionated, CD4 + SP and CD8 + SP subsets whereas the DP 
cells remain negative. Infection can be detected in the DP 
cells by the second week, with significant increases in viral 
burden occurring in all three cell subsets over the following 
2 wk (Fig. 3). In this particular experiment, the viral burden 
in the CD4 + SP  subset  at  1 wk is equivalent to or only 
slightly greater than that in the CD8 + SP subset (titration 
data not shown). However, results from two other experi- 
ments using this viral isolate revealed more clearly that the 
CD4 + SP cells are the initial subset of thymocytes infected, Figure  1.  Histology of the mock- and HIV-infected  SCID-hu human thymus. (A) A typical thymus harvested  2 wk after mock in~'tion and processed 
as described in Materials and Methods. (x 16 magnified Giemsa stain). (B) Staining of the mock-infected thymus with anti-HLA-DR reveals a network 
of DR-positive processes,  most prominent in the medulla which contains a lower number of thymocytes. (C) A  x20 magnified, Giemsa-stained  section 
of thymus (2 wk after infection with JR-CSF) with fibro-adipose  tissue (Ad), Hassall's  corpuscles  (arrow), and underlying mouse kidney (K). (D) Darkfield 
view of ISH staining for HIV RNA of a 2-wk JR-CSF-infected thymus. 
in  that  a positive DNA PCK  signal  was seen in  only the 
unfractionated and CD4 + SP subsets at 3 d after infection, 
with  the  appearance  of virus in  the CD8 +  SP or the DP 
cells lagging behind the CD4 + SP cells by 4-10 d.  In four 
separate  experiments  using  the JR-CSF  isolate,  total  viral 
burden at 8-12 wk after infection, determined by dilutional 
DNA PCK analysis,  varied from 2 to 10% of total thymo- 
cytes and from 0.5 to 10% ofCD4 + SP, 2 to 10% ofCD8 + 
SP, and 0.5 to 5%  of the DP cells.  In all four experiments 
performed thus far with the JK-CSF isolate, viral burden in 
the CD8 + SP subset equaled or surpassed that of the CD4 § 
SP subset by 2-4 wk after infection (Fig. 3). Likewise, a con- 
sistent finding in all experiments using this isolate is the lower 
viral burden seen at later time points after infection in the 
DP thymocytes when compared with either of the SP frac- 
tions (Fig.  3). The positive PCK signals seen in the CD8 + 
thymocyte subset reflects true infection of these cells and could 
not be due to contamination  of the CD8 + cells by infected 
CD4 + thymocytes, in that the subsets were >98% pure and 
the intensity of the PCR signals in the two subsets was similar. 
Indeed, quantitation of viral burden at later time points after 
infection always revealed  an equal or greater burden in the 
CD8 + subset when compared with the CD4 + subset, as in- 
dicated by a stronger PCR signal on serial dilutional analysis 
in  the CD8 + thymocytes (data not  shown). 
In contrast  with  the infection kinetics and viral burden 
found using the JK-CSF isolate, the more virulent SM iso- 
late displayed an accelerated kinetics of infection, with marked 
thymocyte depletion occurring by 3 wk after infection, and 
a higher  viral burden in the DP thymocyte subset than  in 
either  the  CD4 +  SP or CD8 + SP cells  (viral burden  at  3 
wk, "~50% of total thymocytes in two separate experiments, 
with  infection  of 50%  of the  DP  and  10%  each  of the 
CD4 +  and  CD8 +  SP cells).  Additionally,  the  thymocyte 
depletion which was so readily observed histologically (Fig. 
2) was reflected in a predominant  loss of DP and CD4 + SP 
cells when the SM isolate was used (FACS  ~ analysis of thymo- 
cytes from  mock  thymus  revealed  78%  DP,  14%  CD4 +, 
7% CD8 + , and 1% DN compared to thymocytes from the 
3-wk  SM-infected  thymus  which  contained  9%  DP,  5% 
CD4 + ,  58%  CD8 + ,  and 28%  DN).  In contrast,  the JR- 
CSF isolate led to significant depletion of thymocytes much 
later after infection (week 12) and seemed to cause an overall 
decrease in all subsets with a significant loss of DP cells (FACS  | 
1154  HIV Infection of the Human  Thymus/Thymic  Disruption  in SCID-hu Mouse Figure  2.  Thymocyte  depletion  and infection  of  TE cells. Thymuses  from  SCID-hu  mice  were  harvested  at varying  times  after  infection  and examined 
for HIV RNA by ISH and stained  with AE-1 antibody  for identification  of keratin-containing  TE cells. (A) Thymus  infected  for 8 wk with JR-CSF, 
showing  minimal  thymocyte  depletion.  Only  faint  pink (cytokeratin)  staining  of  TE cells  is visible  because  of  overlying  thymocytes.  (B) Thymus  infected 
with SM isolate for 3 wk with marked depletion of thymocytes  revealing the underlying  TE cell network, stained positively  for cytokeratins.  (C) 
This 12-wk  JR-CSF--infected  thymus  reveals some thymocyte  depletion.  A pink-stained,  cytokeratin-containing  TE cell is clearly  seen which  is negative 
for HIV by ISH staining  (amav). In contrast, a cell stained  intensely  positive  by ISH, indicating  active  HIV replication, is seen which  does not stain 
for cytokeratins  and is probably a thymocyte  (arrowhead).  (D) Thymus  infected  with JR-.CSF for 12 wk reveals a TE cell containing  cytokeratins  and 
staining positively  for cytoplasmic  HIV RNA by ISH (amav). 
analysis of thymocytes from mock-infected thymus revealed 
82% DP,  12% CD4 +, 6% CD8 +, and 1% DN compared 
with analysis of 12-wk JR-CSF-infected thymocytes showing 
51% DP,  22%  CD4 +,  23%  CD8 +, and 5% DN).  These 
results are consistent with the thymocyte depletion seen by 
other investigators (33a) using these viral isolates in this model 
of infection. 
To evaluate  whether the DNA PCR results indicated a 
productive HIV infection of these various thymocyte subsets, 
RNA PCR was performed using primers to detect both struc- 
tural (gag) and spliced (tat/rev) KNAs. Fig. 4 is representa- 
tive of the results from three separate experiments. At day 
14 large amounts of  gag RNA were found in the unfraction- 
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ated and CD8 + SP cells while there was a lesser  amount 
found in the DP and CD4 + SP fractions. By day 60, gag 
RNA had increased  in all thymocyte subsets.  These semi- 
quantitative RNA findings paralleled the relative viral burden 
detected in these four subsets by quantitative DNA PCR per- 
formed on duplicate pellets of cells in this experiment (data 
not shown). Messenger RNA for the spliced tat/rev message 
was also present in large amounts in the unfractionated and 
CD8 + SP cells at day 60 with smaller amounts present in 
the DP and CD4 + SP subsets  (Fig.  4).  In two separate ex- 
periments tat/rev  mRNA was detected in the CD4 + and 
CD8 + subsets  as early as 2 wk after infection, whereas it 
was first detected 30 d after infection in the DP fraction in Figure  3.  Increasing  viral burden in JK-CSF--infected  SCID-hu thy- 
muses. SCID-hu mice were killed at increasing  intervals after infection 
and total thymocytes  were harvested, sorted  into SP and DP subsets, and 
analyzed  by DNA PCIL  for the detection  of HIV gag DNA, as described 
in Materials  and Methods.  Results  from  each thymocyte  subset at various 
times after  infection  are shown,  with positive  and negative  controls  (bottom 
panel). Negative  controls  consist  of  mock  (total  thymocytes  from  two sep- 
arate mock infected  mice), lysis  buffer alone (LB), and lysate  from the 
uninfected  Jurkat cell lille. Positive  controls shown  are serial dilutions  of 
lysate  from  the chronically  HIV-infected  ACH-2  cell  line  representing  DNA 
from 1,000, 100, 10, and 1  cells. Resuks  are representative  of  four  separate 
experiments involving  infection  with the JR-CSF isolate. 
one experiment (data not shown). Thus, productive infec- 
tion, as indicated by the presence of  both structural and regula- 
tory viral mRNAs, occurred in all three thymocyte subsets 
after inoculation of the thymus with HIV. 
Morphologic Patterns of  HIV Infection of the Thymus.  In ad- 
dition to the evaluation of individual cell types infected with 
HIV, the histology of the infected thymuses was ultrastruc- 
turaUy examined. In general, two morphologic patterns of 
HIV infection in the thymic tissue were observed, involving 
either predominantly thymocyte  infection (Figs. 5 and 6, pat- 
tern 1) or destruction of TE cells with or without demon- 
strable virus within the cells (Figs. 7 and 8, pattern 2). Both 
morphologic patterns could occur in distinct areas of the same 
individual thymus. 
Examples of the first morphologic pattern, in which thymo- 
cytes are predominantly affected, are shown in Fig. 5. A mul- 
tinucleated giant cell is shown in a thymus infected with the 
SM isolate (Fig. 5 A). This cell is productively infected with 
HIV in that virions were seen budding from the cell surface 
Figure 4.  Productive  infection  of thymocyte  subsets with expression 
of both spliced and unspliced  messages. RNA PCR was performed  on 
RNA extracted from thymocyte  subsets harvested  and sorted at varying 
times after  infection  with JR-CSF, as described  in Materials  and Methods. 
Data shown are from a different  experiment  than  that in Fig. 3, and are 
representative of RNA results obtained  from three separate experiments. 
The results of R.NA-PCR  analysis  are shown  using total RNA harvested 
from the following  numbers of available  cells: (d14) 106 unfractionated, 
DP, and uninfected,  and 5 x  105 CD4+ and CD8 + SP; (drO) 4  x  105 
cells in all infected  subsets for each primer pair, and 106 thymocytes  from 
an uninfected  thymus. 
(Fig.  5,  inset).  Indeed, when infected thymocytes were de- 
tected by TEM they often displayed multiple buds (Fig.  5 
B) indicating active localized viral replication.  This TEM pat- 
tern is consistent with the findings on ISH in which labeling 
of tissue by the HIV-specific probe often indicated loci of 
individual cells possessing large amounts of HIV KNA (Fig. 
1 D). Infection of thymocytes in these thymuses ultimately 
resulted in thymocyte depletion, as is shown strikingly in 
Fig. 6.  Fig.  6 A  shows a mock-infected thymus in which 
the elongated desmosome-linked dendritic-like TE cell pro- 
cesses form a supporting stroma that surrounds individual 
thymocytes. In Fig. 6 B, a section of a thymus infected for 
3 wk with the SM isolate is shown in which the supporting 
TE cell stromal network appears to be relatively healthy and 
intact with preserved junctions between cells, whereas the 
loss of thymocytes is readily apparent in the abundant spaces 
left between TE cells. This marked thymocyte  depletion was 
most easily observed by TEM with the rapidly cytopathic 
SM isolate as compared with the JK-CSF isolate, and occurred 
as early as 2-3  wk after infection. 
The second morphologic pattern observed  in the HIV- 
infected thymuses involved the destruction of the thymic 
microenvironment, most notably infection and/or depletion 
of TE cells. A low power TEM view of a cell with morpho- 
logical features  of a TE cell in a thymus infected for 2 wk 
with JR-CSF is shown in Fig. 7 C with higher power views 
1156  HIV Infection  of the Human Thymus/Thymic  Disruption in SCID-hu Mouse Figure  5.  Morphologic pattern  of HIV infection in the thymus with predominance of thymocyte involvement (pattern  I). Infected thymuses were 
harvested at varying times after in~tion with either the SM or JR-CSF isolate of HIV and processed for TEM analysis as described in Materials and 
Methods.  (,4) A multinucleated  thymocyte,  in a thymus infected with the SM isolate for 3 wk, with three plasma membrane particles (long and short 
arrows). (x 8,000).  The inset is a higher magnification  of one of the budding particles (short arrow). (x 110,000). (B) A  small portion of the surface 
of a large multinucleated  thymocyte in a thymus infected for 2 wk with JR-CSF with mature particles having a conical nucleoid  (short arrow) and 
several budding particles  (long arrows). (x63,000). 
of this cell shown in the other panels. Although this cell ap- 
pears healthy, HIV is present, clustered both extracellularly 
(Fig. 7 B) and in vacuoles within the cell (Fig. 7, A  and D). 
HIV was observed both in coated vacuoles (Fig. 7 D), pos- 
sibly indicating endocytosis of HIV by TE cells, as well as 
in multivesicular bodies, a component of the Golgi complex 
(Fig.  7 A). In the examination of multiple thymuses, HIV 
was frequently seen intimately associated with cells clearly 
identified as TE cells by the presence of desmosomes and in- 
tracellular  tonofilaments. These data, in combination with 
the ISH/IHC data shown in Fig.  2 D,  indicate that HIV 
is contained within TE cells in this model of human thymopoi- 
esis, although productive infection of these cells could not 
be formally demonstrated. 
Another feature of the second pattern of morphologic in- 
volvement of the thymus after  HIV infection is shown in 
Fig.  8.  In this thymus harvested 2 wk after infection with 
theJR-CSF isolate, no obvious infection of TE cells, thymo- 
cytes, or free HIV virions are seen in this microscopic field, 
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yet marked toxicity to a portion of the TE cells has occurred. 
Healthy TE cells are seen in the periphery of the field, still 
attached by junctions to obviously abnormal vacuolated and 
degenerating TE cells. Despite this TE cell degeneration, the 
thymocytes within the field appear normal. These morpho- 
logic findings are consistent with a toxic insult to these par- 
ticular TE cells resulting in degeneration of this area of the 
supporting stromal network. 
Thus, one morphologic pattern is that of exuberant viral 
replication by  individual thymocytes, formation of mul- 
tinucleated giant cells with budding virus, and marked thymo- 
cyte depletion. In contrast, a second pattern involves altera- 
tion of the thymic microenvironment. In this pattern, TE 
cells contain HIV and are destroyed, either by HIV itself or 
by some currently unidentified HIV-associated toxic stimulus. 
Although both morphologies could be  seen in  the  same 
thymus, infection with the SM isolate generally resulted in 
a predominance of thymocyte involvement whereas the JR- 
CSF isolate led to TE cell involvement and destruction in Figure 6.  Thymocyte  depletion  in the HIV-infected  thymus  compared with the normal thymus. (A) TEM of a fidd from a 2 wk mock-infected 
explant showing  thymocytes  intimately  associated  with the cell bodies and processes (long arrows) of four thymic  epithelial  cells. These TE cells have 
large nuclei with little heterochromatin  and one or two small  nucleoli. Many  electron-dense  desmosomes  join TE cells  (short arrows). (B) An area of 
thymocyte  drop-out is shown  in a 3 wk SM-infected  thymus,  in which primarily  empty spaces separate TE cells and their many  processes. Abundant 
dectron-dense cytokeratin  is seen in all of the TE cells (arrows). (x5,200). 
addition to the thymocyte  infection readily detected by PCR 
analysis. 
Discussion 
This study demonstrates that intrathymic injection of pri- 
mary isolates of HIV results in the reproducible infection of 
multiple subsets of thymocytes as well as the presence of HIV 
within TE  cells,  leading to  depletion  of thymocytes and 
damage to the thymic microenvironment. Whereas DNA 
and RNA PCR analyses indicated productive infection of 
CD4 + and CD8 + SP as well as DP thymocytes, the pattern 
of infection and viral burden differed both within the three 
thymocyte subsets  and between the two viral isolates used. 
These findings expand upon previous observations of thymo- 
cyte depletion after infection of the SCID-hu mouse with 
primary isolates  of HIV (33). 
The reproducible finding of HIV infection within the SP 
CD8 + thymocytes was surprising. Infection in this subset 
of cells could reflect infection of DP cells with a resultant 
decreased surface expression of the CD4 molecule. This seems 
somewhat unlikely, however,  since the viral burden in the 
DP cells was always significantly less than that seen in the 
CD8 SP cells (using the JK-CSF isolate),  and it is difficult 
to envision that modulation of the CD4 molecule could occur 
with such rapid kinetics to give these results.  Alternatively, 
CD8 +  cells,  particularly  more  immature  cells,  may  still 
possess  a small amount of CD4 on their surface resulting 
in susceptibility of these cells to infection by HIV. The sub- 
sequent high viral burden observed in this subset might then 
reflect the balance between a similar susceptibility of CD4 + 
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cytotoxicity for the CD8 + cells,  since cytotoxicity has  pre- 
viously been positively correlated with levels of expression 
of CD4 on the surface of an infected cell (34, 35). A  third 
potential explanation is that infection occurs in the so called 
"triple negative" (TN, CD3-CD4-CDS-)  thymic precursor 
cells,  a subset that  has been previously demonstrated  to be 
infectable in vitro (7). The infected TN cell might  then be 
preferentially driven to mature along the CD8 SP pathway, 
resulting  in  an  accumulation  of infected  CD8 +  SP  cells. 
Since TN  cells  comprise an extremely small percentage  of 
the population of thymocytes harvested from these SCID-hu 
thymuses (cells staining negatively for both CD4 and CD8 
generally <1.5% by FACS  |  analysis,  data not shown), it has 
not been possible thus far to purify these cells for detection 
of  HIV  infection.  Finally,  relatively  mature  SP  CD8 + 
thymocytes could become infected in the thymic microen- 
vironment  by a cell-cell mechanism,  much like that which 
has been previously reported to occur after coculture with 
mature peripheral blood T  cells from HIV-infected individ- 
uals (36).  Whereas circulating  mature  CD8 + cells are not 
infected with HIV (23), De Maria et al.  (36) demonstrated 
that  coculture  of mature  peripheral  blood  CD8 +  T  cells 
with autologous infected CD4 + T  cells from seropositive in- 
dividuals resulted in the ability to derive CD8 + T  cell clones 
from these cultures which were productively infected with 
HIV.  This in vitro infection was presumably the result  of 
culturing  the previously uninfected  CD8 +  T  cells  with  a 
higher number or concentration of productively infected au- 
tologous CD4 + cells than that which is seen in the circula- 
tion in vivo. In this regard,  the close environment of the SCID- 
hu human  thymus may well provide an appropriate milieu 
such that  cell-mediated infection  of CD8 + SP thymocytes 
can occur. Since infected CD8 + cells are not seen in the pe- 
ripheral  circulation of seropositive individuals,  the fate of these 
cells is uncertain.  Whether  intrathymic  death or tissue se- 
questration  occurs  remains  an  area  for further  evaluation. 
Studies are ongoing to delineate whether mature or imma- 
ture CD8 + thymocytes are infected with HIV and to deter- 
mine the mechanism of this inf~tion and the fate of these cells. 
1159  Stanley  et al. Figure 7.  HIV within TE cells. An infected ~ttened TE cell from a 
2 wk JR-CSl~--infected  thymus is shown in panel c with higher magnifica- 
tions of several of its associated virions also shown.  The lettered arrows 
in c refer to areas of the cell shown in the corresponding  pands. (a) A 
mature particle is seen within a multivesicular body (cytophsmic vacuole). 
(b) A budding partide and several  mature particles are seen along the plasma 
membrane of the cell. The eaact cen from which these virions originated 
cannot be determined. (c) The TE cell in dose contact with several  thymo- 
cytes. (d) A mature partide within a coated vesicle (lower/eft) is observed 
in the cytoplasm of this TE cell in a different section but in the approxi- 
mate area indicated by arrow d in c. a, b, and d,  ￿  110,000; c,  x 10,000. 
1160  HIV Infection  of the Human Thymus/Thymic Disruption in SCID-hu Mouse Figure 8.  TE cell degeneration  in the infected  thymus. In this thymus harvested 2 wk after infection  with JR-CSF, more  normal-appearing  TE 
cell processes  (p), with occasional  swollen  mitochondria  and electron-dense  lipid  vacuoles  (long arrow pointing  to mitochondrion  touching  lipid vacuole) 
are attached by desmosomes  (short arrows) to the dectron-lucent  degenerating  TE cells (d). No virions are seen in this rid& (x6,500). 
Involvement of the TE cell in this infected tissue was ex- 
amined by both TEM and ISH/IHC techniques. IHC/ISH 
double labeling demonstrated the presence of keratin-con- 
taining TE cells stained positively for HIV RNA, whereas 
TEM examination revealed HIV intracellularly and intimately 
associated with TE cells, although budding virus could not 
be definitively shown. In this regard, it is possible that the 
positive signal seen by ISH in TE cells may reflect the pres- 
ence of intracellular viral RNA and not mRNA, and the in- 
ternalization of virus may not result in productive infection 
of these cells.  Nevertheless, the demonstration of intracel- 
lular HIV in TE cells in the SCID-hu human thymus is of 
considerable interest. Previous studies (12-16) have demon- 
strated  that  thymuses  from  HIV-infected  individuals  are 
markedly abnormal and display evidence of premature invo- 
lution and TE cell toxicity. Whereas ISH results obtained 
by Schuurman et al.  (14) were suggestive of TE cell infec- 
tion, this phenomenon has not been definitively demonstrated 
in vivo.  In vitro infection of cultured TE cells has been ac- 
complished resulting in a transient low level production of 
p24 and TE cell death by 8-10 d (37), although it is unclear 
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whether contaminating thymocytes  or other cells were present 
in  the initial cultures. Our data indicate that TE cells be- 
come infected with HIV in vivo, but the presence of HIV 
did not seem to correlate with destruction of the TE cell. 
This difference in TE cell cytopathology could be due to the 
differences between an in vivo versus an in vitro systom. As 
an example, HLA-DK is constitutively expressed by TE cells 
in the thymus, whereas cultured TE cells do not express this 
antigen unless exogenous IFN-y is added to the media (38). 
Additionally, there are multiple subtypes of TE cells within 
the thymus representing different stages of maturation and 
different functions and containing variable amounts of cytoker- 
atins (30).  These can be identified by the expression of an- 
tigens that distinguish medullary and subcapsular endocrine 
functioning TE cells from the cortical TE cells.  In fact, as 
many as six different types of TE cells have been identified 
ultrastructurally  (39).  Studies  are  ongoing  to  determine 
whether there are differences in susceptibility to HIV infec- 
tion among TE cell subsets and to delineate any functional 
alterations that may occur in these cells. The lack of toxicity 
noted in TE cells containing HIV (e.g., Fig. 7) might be a function of the timing of tissue harvest after infection,  or 
may indicate that infection in vivo is chronic, noncytopathic, 
and  nonproductive  or  associated with  low levels  of virus 
production,  similar to the pattern of infection observed in 
tissue macrophages.  In this regard,  the majority of imma- 
ture particles seen in these tissues were budding from thymo- 
cytes, suggesting that the virus within TE cells is indeed ei- 
ther nonreplicative or associated with only a low level of virus 
production as compared with thymocytes. This would have 
significant implications for the potential role of these cells 
as a viral reservoir in which newly developing and suscep- 
tible thymocytes are chronically exposed to HIV.  Current 
studies in this laboratory are  addressing  these issues. 
TE cell toxicity was noted that was seemingly unrelated 
to productive infection of these cells. One can speculate that 
infection and destruction of thymocytes could result in their 
failing to produce TE trophic factors such as IFN-3' or IL-2, 
resulting in death of the TE cells. However, in some instances 
we have observed destruction  of TE cells before depletion 
of thymocytes. Alternatively, cross-reactivity occurs between 
the HIV p19 and gp41 proteins and TE cell antigens  such 
as HLA-DR (40, 41), such that an immune response mounted 
against HIV might  target  normal TE cells.  However, this 
is unlikely to occur in the SCID-hu thymus. It is dear that 
the thymic microenvironment is a complex tissue requiring 
the intact function of thymocytes, TE cells,  and even fibro- 
blasts (30) for normal development, growth, and T cell matu- 
ration. The mechanism by which HIV disrupts this environ- 
ment is an area  of ongoing investigation. 
In summary, infection of the human thymus in the SCID-hu 
mouse results in infection of both distinct thymocyte subsets 
and TE cells. Thymocyte depletion and TE cell degeneration 
occur. The depletion of thymocytes by HIV infection and, 
in particular,  the ability of HIV to disrupt the TE cell sup- 
porting  framework of the thymus,  has broad implications 
for therapies aimed at reconstitution of the immune system 
in HIV-infected individuals. 
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